Crossmark

Prognostic Impact of Osteopenia in Patients Who Underwent Living Donor Liver Transplantation for Hepatocellular Carcinoma

Crossref DOI link: https://doi.org/10.1007/s00268-019-05206-5

Published Online: 2019-10-17

Published Print: 2020-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Toshima, Takeo

Yoshizumi, Tomoharu

Kosai‐Fujimoto, Yukiko

Inokuchi, Shoichi

Yoshiya, Shohei

Takeishi, Kazuki

Itoh, Shinji

Harada, Noboru

Ikegami, Toru

Soejima, Yuji

Mori, Masaki
Funding

Funding for this research was provided by:

Japan Agency for Medical Research and Development (17fk0210305h0003, 18fk0210023h0002)

Japan Society for the Promotion of Science (JP‐16K06432, JP‐16K10577)

Japan Agency for Medical Research and Development (17fk0210305h0003, 18fk0210023h0002)

Japan Society for the Promotion of Science (JP-16K06432, JP-16K10577)
License Information

Version of Record valid from 2019-10-17

Text and Data Mining valid from 2019-10-17

Version of Record valid from 2019-10-17
More Information

Article History

First Online: 17 October 2019

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional review board of ethics committee and national research committee with the 1964 Helsinki declaration and its later amendments.

: Informed consent was obtained from all individual participants included in the study.